For instance, N-Myc amplification changes the classification and worsens the prognosis of spinal cord ependymoma, as do H3 K27M, TP53, and TERT promoter mutations, among many, worsen the prognosis of astrocytomas. Here, MYCN is linked to spinal cord ependymoma.